Introduction to ICP spectroscopy
Monday, April 4, 2022
Join our “Introduction to ICP spectrometry” educational webinar series and learn how to optimize daily routines in your trace e lemental analysis with   ICP-OES and ICP-MS  . Our experts  will demonstrate best practice from sample prep to data evaluation and provide you valuable tips and tricks to simplify and enhance your analytical performance. Register and watch webinar >  Webinar agenda: Introduction to ICP spectrometry: Part 1 April 4, 2022 | 10:00 BST | 11:00 CEST Sample Prep – creating serial dilutions from stock standards Sample introduction options and considerations – matrix matching, physical and chemical interferences Inductively Coupled Plasma – RF, plasma effects ICP-OES and ICP-MS cleaning and maintenance Introduction to ICP spectrometry: Part 2 April 5, 2022 | 10:00 BST | 11:00 CEST System Optimization – Performance reports, Mass Cal/Cross Cal, KED interface cleaning, Conditioning Method development – Correct wavelength/viewing mode and isotope selection, interferences – spectral and m/z, determine correct internal standards to use and validation of method Data evaluation – correcting for background and interferences, stability, and sensitivity verification, Examine calibration curves for R2, LOD and saturation, QC data, carryover, and drift correction Can’t attend at these times? Register anyway and automatically receive the recordings to watch at your convenience.
Event has ended
Toward A Next-Generation MAM: An Evaluation of the Orbitrap Exploris MX Mass Detector Webinar
Wednesday, May 25, 2022
  In the development of biotherapeutics, a thorough understanding of a molecule’s product quality attributes (PQAs), and their effect on various structure-function relationships and long-term stability, is essential for ensuring the safety and efficacy of the product. At present, numerous routine chromatographic and electrophoretic assays are used to characterize and monitor individual PQAs. However, execution of multiple routine methods for batch release, stability time-points, and process/formulation development support becomes time and resource intensive, and often provides an indirect measure of biologically relevant PQAs. Introduced in 2015, the multi-attribute method (MAM), based on LC-MS peptide mapping and automation principles, provides simultaneous and site-specific detection, identification, quantitation, and quality control (monitoring) of PQAs.   A dedicated Pfizer team has been regularly employing MAM on an in-house MAM platform to support biotherapeutic process and product development. In parallel, this team has continually explored and implemented improvements in the Pfizer MAM platform, including sample preparation and data processing automation, to move toward the next generation of MAM. Recently, a pre-commercial demo model of the new Thermo Scientific Orbitrap Exploris MX mass detector was evaluated in-house by the Pfizer MAM team. Here, the results of the evaluation and an assessment of the Orbitrap Exploris MX mass detector’s suitability as a next generation MAM instrument are presented.   Learn: Pfizer MAM platform milestones for characterization and routine monitoring Automation of sample handling and data processing and reporting Evaluation and optimization of the Orbitrap Exploris MX mass detector for MAM REGISTER HERE
Event has ended
Virtual Trivia Leaderboard

Please congratulate the winners to our last trivia challenge!

  1. Helix_Heroes
  2. NMS
  3. erictague
united states flag icon United States